demonstrated an increased frequency of BM-infiltrating immunosuppressive M2 macrophages expressing TIGIT, TIM-3, and LAG-3 in patients with newly diagnosed and relapsed AML (157). This evidence concerns the gene HAVCR2 and acute myeloid leukemia.